Journal
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Volume 31, Issue -, Pages S84-S88Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00126334-200210012-00009
Keywords
neuroprotection; oxidative stress; antioxidants; HIV/AIDS
Categories
Funding
- FIC NIH HHS [D43TW00017] Funding Source: Medline
- NIDA NIH HHS [R01DA12797] Funding Source: Medline
Ask authors/readers for more resources
Impaired neuroprotection resulting from oxidative stress has been implicated in neurodegeneration in a number of pathologic conditions of the brain, including both subcortical and cortical type dementias. Production of excessive oxidative stress, moreover, can lead to elevated levels of certain proinflammatory cytokines that are considered to be contributing factors to neuronal injury and are evident in HIV-related dementia as well as in other neurodegenerative conditions. Inhibitors of oxidative damage could thus be promising therapeutic agents for preventing progressive nerve cell death and slowing the advance of neurodegenerative disease. The potential of antioxidant therapy to provide neuroprotection is substantiated by studies demonstrating reduced oxidative stress with supplementation and lower risk for cognitive impairment with higher plasma antioxidant levels.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available